Anderman Todd 4
4 · OCULAR THERAPEUTIX, INC · Filed Oct 9, 2024
Insider Transaction Report
Form 4
Anderman Todd
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-07+296,500→ 296,500 totalExercise: $9.48Exp: 2034-10-06→ Common Stock (296,500 underlying) - Award
Common Stock
2024-10-07+98,700→ 98,700 total
Footnotes (2)
- [F1]On October 7, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on the date of grant.
- [F2]Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter.